All Insiders Activity for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.428 R     -0.1383 (-24.42%) Volume: 53.23m 4:00 PM EDT Aug 6, 2020
After Hours:  $ 0.4265   -0.0015 (-0.35%) Volume: 661.4k 7:59 PM EDT Aug 6, 2020
Name: Transaction:
Date Name: Shares Transaction Value
07/13/18 Mark S. Berger,
Chief Medical Officer
250,000 Acqusition at $0.783 per share. $195,750
07/13/18 Sandesh Seth,
Director, Chairman & CEO
1,000,000 Acqusition at $0.783 per share. $783,000
07/13/18 Richard I. Steinhart,
75,000 Acqusition at $0.783 per share. $58,725
07/13/18 Jeffrey W. Chell,
75,000 Acqusition at $0.783 per share. $58,725
07/13/18 C. David Nicholson,
75,000 Acqusition at $0.783 per share. $58,725
07/13/18 Steven O'Loughlin,
Principal Financial Officer
265,000 Acqusition at $0.783 per share. $207,495
07/13/18 Nitya G. Ray,
Executive VP
75,000 Acqusition at $0.783 per share. $58,725
07/13/18 Ajit S. Shetty,
75,000 Acqusition at $0.783 per share. $58,725
06/15/18 Steven O'Loughlin,
Principal Financial Officer
12,000 Buy at $0.50 per share. $6,000
04/19/18 Sandesh Seth,
Director, Chairman & CEO
5,000 Buy at $0.38 per share. $1,900
03/06/18 Richard I. Steinhart,
7,000 Other at $0.50 per share. $3,500
03/06/18 Steven O'Loughlin,
Principal Financial Officer
10,000 Other at $0.50 per share. $5,000
03/06/18 Sandesh Seth,
Director, Chairman & CEO
52,500 Other at $0.50 per share. $26,250
03/06/18 Nitya G. Ray,
Executive VP
10,000 Other at $0.50 per share. $5,000
03/06/18 Mark S. Berger,
Chief Medical Officer
14,000 Other at $0.50 per share. $7,000
  Previous Page Page 2 of 6   Next Page
View Section 16 Filings (Forms 3,4,5) for ATNM Insider Summary For ATNM